glp-1 and cardiovascular benefits Receptor Agonists for the Reduction of Atherosclerotic Risk in Patients With Type 2 Diabetes While GLP-1 drugs are known

In the CNS, GLP-1Rs are expressed by neurons in the hippocampus, which is known to be a cognition-related brain region, and have been observed in neocortical pyramidal neurons (Hamilton and Holscher, 2009)

Conclusion Our study highlights the potential utility of alternative dosing regimens of incretin mimetics

Wegovy is taken once a day on an empty stomach

Patients should avoid storing tirzepatide in areas with temperature extremes, such as car glove compartments, near windows with direct sunlight, or in bathrooms where humidity and temperature fluctuate significantly

However, because DOACs have predictable pharmacokinetics and do not require routine monitoring, the clinical risk is lower

While these medicines are generally safe, many people have reported some side effects 1 , especially during the early stages of treatment 2